Cures Bill Keeps Software Used In Blood Transfusions Under FDA Oversight

The 21st Century Cures bill unanimously passed by the House Energy and Commerce Committee Thursday (May 21) includes slightly updated language based on legislation introduced earlier this week by Reps. Marsha Blackburn (R-TN) and Gene Green (D-TX) aimed at ensuring software used in the manufacturing and transfusion of blood and blood components to assist in the prevention of disease in humans is not removed from FDA oversight. The Cures bill removes low-risk devices that fit into the legislation's definition of...